International Stem Cell Corp's CFO Sophia Garnette resigns effective April 1, 2022

International Stem Cell CORP

Sophia Garnette, Principal Financial Officer and VP of Legal Affairs and Operations, submitted resignation.
Resignation effective April 1, 2022.
Company evaluating alternatives for successor principal financial officer.
Garnette will assist with transition once successor is identified.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sophia Garnette

Principal Financial Officer and VP of Legal Affairs and Operations

ISCO · International Stem Cell CORP

Effective: 2022-04-01
Filed: February 2, 2022, 6:59 PM ET

On February 1, 2022, Sophia Garnette, Principal Financial Officer and VP of Legal Affairs and Operations of International Stem Cell Corporation (the "Company"), submitted her resignation, to be effective on April 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sophia Garnette resigned as Principal Financial Officer and VP of Legal Affairs and Operations at International Stem Cell CORP.

Action: resigned
Role: Principal Financial Officer and VP of Legal Affairs and Operations

Exact text from the filing

On February 1, 2022, Sophia Garnette, Principal Financial Officer and VP of Legal Affairs and Operations of International Stem Cell Corporation (the "Company"), submitted her resignation, to be effective on April 1, 2022.

View on SEC.gov

International Stem Cell CORP filing history →

Source: SEC EDGAR

accession 0001564590-22-003423

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.